Works about ADENOSINE diphosphate ribose


Results: 183
    1

    A Covalent Binding Mode of a Pyrazole‐Based CD38 Inhibitor.

    Published in:
    Helvetica Chimica Acta, 2023, v. 106, n. 9, p. 1, doi. 10.1002/hlca.202300080
    By:
    • Doyle, Kevin;
    • Roberts, Maxine;
    • Harvey, Jenna;
    • Hewer, Richard;
    • Zebisch, Matthias;
    • Rangel, Victor;
    • Gu, Meigang;
    • Wu, Yiming;
    • Yang, Lichao;
    • Carlton, Mark;
    • Dawson, Lee;
    • Bürli, Roland
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Oxidized Phosphatidylcholines Trigger TRPA1 and Ryanodine Receptor-dependent Airway Smooth Muscle Contraction.

    Published in:
    American Journal of Respiratory Cell & Molecular Biology, 2023, v. 69, n. 6, p. 649, doi. 10.1165/rcmb.2022-0457OC
    By:
    • Vaghasiya, Jignesh;
    • Dalvand, Azadeh;
    • Sikarwar, Anurag;
    • Mangat, Divleen;
    • Ragheb, Mirna;
    • Kowatsch, Katarina;
    • Pandey, Dheerendra;
    • Hosseini, Seyed Mojtaba;
    • Hackett, Tillie L.;
    • Karimi-Abdolrezaee, Soheila;
    • Ravandi, Amir;
    • Pascoe, Christopher D.;
    • Halayko, Andrew J.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    CD38 promotes hematopoietic stem cell dormancy.

    Published in:
    PLoS Biology, 2024, v. 22, n. 2, p. 1, doi. 10.1371/journal.pbio.3002517
    By:
    • Ibneeva, Liliia;
    • Singh, Sumeet Pal;
    • Sinha, Anupam;
    • Eski, Sema Elif;
    • Wehner, Rebekka;
    • Rupp, Luise;
    • Kovtun, Iryna;
    • Pérez-Valencia, Juan Alberto;
    • Gerbaulet, Alexander;
    • Reinhardt, Susanne;
    • Wobus, Manja;
    • von Bonin, Malte;
    • Sancho, Jaime;
    • Lund, Frances;
    • Dahl, Andreas;
    • Schmitz, Marc;
    • Bornhäuser, Martin;
    • Chavakis, Triantafyllos;
    • Wielockx, Ben;
    • Grinenko, Tatyana
    Publication type:
    Article
    30
    31
    32

    Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz085
    By:
    • Rugo, Hope S;
    • Ettl, Johannes;
    • Hurvitz, Sara A;
    • Gonçalves, Anthony;
    • Lee, Kyung-Hun;
    • Fehrenbacher, Louis;
    • Mina, Lida A;
    • Diab, Sami;
    • Woodward, Natasha E;
    • Yerushalmi, Rinat;
    • Goodwin, Annabel;
    • Blum, Joanne L;
    • Martin, Miguel;
    • Quek, Ruben G W;
    • Tudor, Iulia Cristina;
    • Bhattacharyya, Helen;
    • Gauthier, Eric;
    • Litton, Jennifer K;
    • Eiermann, Wolfgang
    Publication type:
    Article
    33
    34
    35
    36

    The PARP Way to Epigenetic Changes.

    Published in:
    Genes, 2021, v. 12, n. 3, p. 446, doi. 10.3390/genes12030446
    By:
    • Ummarino, Simone;
    • Hausman, Clinton;
    • Di Ruscio, Annalisa;
    • Piunti, Andrea
    Publication type:
    Article
    37
    38

    Expanding anti-CD38 immunotherapy for lymphoid malignancies.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02421-2
    By:
    • Wang, Xu;
    • Yu, Xinfang;
    • Li, Wei;
    • Neeli, Praveen;
    • Liu, Ming;
    • Li, Ling;
    • Zhang, Mingzhi;
    • Fang, Xiaosheng;
    • Young, Ken H.;
    • Li, Yong
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50